Table 2 Clinical follow-up of dystrophic dogs. The clinical score of the naïve Golden Retriever Muscular Dystrophy (GRMD) and MuStem cell-treated GRMD (GRMDT) dogs was determined weekly by semi-quantitative evaluation of 17 individual clinical parameters. The evolution of the clinical score was determined between the 1st transplantation and the animal's sacrifice. The age of each dog at sacrifice is expressed in weeks.
Animals | Clinical score | |||||
|---|---|---|---|---|---|---|
Group | ID number | Age at sacrifice | At inclusion (%) | At 1st injection (%) | At sacrifice (%) | Evolution during the experiment (%) |
GRMDT | 1 | 40.0 | 90.0 | 87.3 | 76.2 | −11.0 |
2 | 40.1 | 89.1 | 88.3 | 87.0 | −1.2 | |
3 | 39.7 | 89.5 | 74.7 | 76.1 | 1.4 | |
4 | 37.9 | 89.2 | 82.0 | 75.1 | −6.9 | |
GRMD | 5 | 47.6 | 93.9 | 92.1 | 72.6 | −19.5 |
6 | 37.9 | 79.8 | 83.7 | 41.4 | −42.3 | |
7 | 33.6 | 90.0 | 75.1 | 23.3 | −51.8 | |
8 | 47.4 | 91.9 | 90.8 | 71.2 | −19.6 | |
